# International Journal of Rheumatic Diseases

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/international-journal-of-rheumatic-diseases/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,350 |
| Citations | 54,612 |
| h-index | 79 |
| Homepage | https://onlinelibrary.wiley.com/journal/1756185X |
| Open Access | false |
| ISSN-L | 1756-1841 |
| ISSNs | 1756-1841,1756-185X |
| OpenAlex ID | https://openalex.org/S169069398 |
| Publisher | Wiley |
| Works | 5,130 |

## Journal papers

Showing 12 of 21.

- [2018 update of the APLAR recommendations for treatment of rheumatoid arthritis](https://scholariq.org/papers/2018-update-of-the-aplar-recommendations-for-treatment-of-rheumatoid-arthritis/)
- [Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan](https://scholariq.org/papers/management-of-gout-and-hyperuricemia-multidisciplinary-consensus-in-taiwan/)
- [<scp>APLAR</scp> rheumatoid arthritis treatment recommendations](https://scholariq.org/papers/scp-aplar-scp-rheumatoid-arthritis-treatment-recommendations/)
- [Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia](https://scholariq.org/papers/risk-of-tuberculosis-with-anti-tumor-necrosis-factor-therapy-substantially/)
- [Low‐dose and high‐dose methotrexate are two different drugs in practical terms](https://scholariq.org/papers/low-dose-and-high-dose-methotrexate-are-two-different-drugs-in-practical-terms/)
- [Development of the Asia Pacific Lupus Collaboration cohort](https://scholariq.org/papers/development-of-the-asia-pacific-lupus-collaboration-cohort/)
- [Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity](https://scholariq.org/papers/serum-levels-of-visfatin-resistin-and-adiponectin-in-patients-with-psoriatic/)
- [Adalimumab significantly reduces inflammation and serum <scp>DKK</scp>‐1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis](https://scholariq.org/papers/adalimumab-significantly-reduces-inflammation-and-serum-scp-dkk-scp-1-level-but/)
- [Renal involvement in primary Sjögren's syndrome: A retrospective study of 103 biopsy‐proven cases from a single center in China](https://scholariq.org/papers/renal-involvement-in-primary-sjogren-s-syndrome-a-retrospective-study-of-103/)
- [Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation](https://scholariq.org/papers/reactivation-of-hepatitis-b-virus-infection-following-rituximab-treatment-in/)
- [Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan](https://scholariq.org/papers/risk-of-tuberculosis-serious-infection-and-lymphoma-with-disease-modifying/)
- [Distinct impacts of syndesmophyte formation on male and female patients with ankylosing spondylitis](https://scholariq.org/papers/distinct-impacts-of-syndesmophyte-formation-on-male-and-female-patients-with/)

## Journal top topics

Showing 8 of 25.

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Gout, Hyperuricemia, Uric Acid](https://scholariq.org/topics/gout-hyperuricemia-uric-acid/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.